A recent study, approved by the Rey Juan Carlos University of Madrid and the Spanish Agency for Medicines and Healthcare Products (AEMPS), certifies the suitability and effectiveness of the intracavitary INDIBA® ACTIV treatment to reduce chronic pelvic pain. The results have just confirmed, therefore, the safety and performance of INDIBA radiofrequency at 448 kHz to treat this condition. We explain what the advances are and detail what this novelty implies in clinical research!
WHAT IS THE PELVIC FLOOR?
The pelvic floor is the anatomical structure that supports the weight of the abdominal viscera, makes it possible for the pelvic organs to be in a healthy position and is composed of muscles, ligaments and fascia (connective tissue). It is estimated that a third of the female population can suffer a weakening of the pelvic floor due to processes such as pregnancy or weakening of the musculature, although it is also common among men.
If this tissue is not properly hydrated, if it has been overloaded, has hardened or has a chemical disorder, it can cause muscle contractions or overloads, pelvic pain, incontinence or pain in sexual relationships, sometimes even making them impossible.
HOW WAS THE STUDY ON CHRONIC PELVIC PAIN?
In this case of clinical research, 49 adult patients, men and women, affected by chronic pelvic pain of inflammatory origin participated. To carry out the study, two groups were created; one of them received a treatment with INDIBA® ACTIV and the other received a placebo treatment (no current was applied).
These two groups allowed an evaluation and enabled the researchers to make comparisons on changes in pain intensity, effectiveness and tolerance of INDIBA® ACTIV treatment over time. All of them received ten 45-minute sessions for four months and were complemented with manual therapy.
WHAT WERE THE RESULTS OF THE STUDY OF PELVIC PAIN?
This new study validates the intracavitary treatment of INDIBA® ACTIV. On one hand, it certifies that it is effective in reducing the intensity of pelvic pain of inflammatory origin in a significant way and on the other, it ensures that the equipment at 448 kHz of INDIBA activ is “very safe” and “well tolerated”. In addition, it confirms that the use of the Proionic Activ cream is an ideal complement to facilitate the physiotherapist’s work during the treatment.
Therefore, this case opens new lines of work for the development of treatments that contribute to strengthen the pelvic floor through the INDIBA® ACTIV device.
WHAT OTHER BENEFITS DOES THE INDIBA® ACTIV TREATMENT PROVIDE FOR PELVIC FLOOR?
The INDIBA treatment facilitates the control of incontinence, recovers tears and episiotomies and minimizes the risk of hemorrhoids. It also relieves inflammation, reduces chronic pelvic pain and it is recommended for rehabilitation after surgery.
The reinforcement of this area improves sexual relations because it promotes the control of ejaculation and prevents prostatitis. Also, this therapy contributes to the improvement in the toning of the vaginal muscles – improving or preventing dyspareunia (pain during intercourse), contributes to palliate vaginal dryness and promotes recovery after delivery.